BlackRock Institutional Trust’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$600K Buy
570
+254
+80% +$115K ﹤0.01% 3420
2016
Q3
$126K Hold
316
﹤0.01% 3673
2016
Q2
$130K Hold
316
﹤0.01% 3673
2016
Q1
$135K Hold
316
﹤0.01% 3681
2015
Q4
$182K Buy
316
+220
+229% +$154K ﹤0.01% 3662
2015
Q3
$85K Buy
96
+87
+967% +$79.3K ﹤0.01% 3751
2015
Q2
$9K Buy
+9
New +$10.5K ﹤0.01% 3887
2014
Q2
Sell
-276
Closed -$449K 4060
2014
Q1
$449K Buy
276
+77
+39% +$161K ﹤0.01% 3590
2013
Q4
$257K Buy
199
+121
+155% +$193K ﹤0.01% 3683
2013
Q3
$156K Buy
+78
New +$145K ﹤0.01% 3713

Other funds holding HSTO

BlackRock Institutional Trust's HSTO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Histogen Inc. Common Stock (HSTO) stake by 80% in Q4 2016, buying an estimated $115K and bringing the position to 570 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #3420.

BlackRock Institutional Trust first reported a position in HSTO in Q3 2013 and has held it in 10 quarters since. 41 funds tracked by Wall St. Rank hold HSTO as of Q4 2016.

  • BlackRock Institutional Trust held 570 shares of Histogen Inc. Common Stock worth $600K as of Q4 2016.
  • BlackRock Institutional Trust bought 254 Histogen Inc. Common Stock shares in Q4 2016, an estimated $115K.
  • Histogen Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3420 holding.
  • BlackRock Institutional Trust first reported a position in Histogen Inc. Common Stock in Q3 2013 and has held it in 10 quarters since.
  • 41 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.